AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17609220
Drug: Oral glucocorticoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucocorticoid (20 mg of prednisolone)
Trial: 9059095
Drug: Laryngeal mask
RxNorm normalized name: MASK
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laryngeal mask (group L)
Trial: 2425671
Drug: Combined Urokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Urokinase (UK) and Dextran Sulfate (DS) - UK: 2.84 X 10(5) units and DS: 3000 mg for one day
Trial: 16433601
Drug: Aggressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive treatment (acetaminophen 650 mg every 6 h for temperature >38.5 degrees C and cooling blanket for temperature >39.5 degrees C)
Trial: 16433601
Drug: Permissive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permissive treatment (no treatment for temperature >38.5 degrees C, treatment initiated at temperature >40 degrees C with acetaminophen and cooling blankets)
Trial: 18398080
Drug: Aggressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive treatment
Trial: 16433601
Drug: Permissive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permissive treatment
Trial: 14597105
Drug: Interferon (IFN)-beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon (IFN)-beta-1a (Rebif(R)) therapy for 1 year
Trial: 14597105
Drug: Prior to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior to treatment
Trial: 10595630
Drug: Clopidogrel 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 50 mg/od
Trial: 10595630
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg/bid
Trial: 9226734
Drug: Amisulpride 50
RxNorm normalized name: amisulpride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 50 mg
Trial: 10890311
Drug: Amisulpride 200
RxNorm normalized name: amisulpride 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 200 mg
Trial: 11123382
Drug: Ethanol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.8 g/kg)
Trial: 8911882
Drug: Amisulpride 50
RxNorm normalized name: amisulpride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 50 mg and 200 mg
Trial: 6108756
Drug: Oral beta-blockers
RxNorm normalized name: beta carotene Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral beta-blockers (atenolol and propranolol) combined with topical epinephrine
Trial: 6108756
Drug: Timolol (local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (local beta-blocker)
Trial: 25348661
Drug: Entecavir (ETV)
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir (ETV) monotherapy (0.5 mg/day)
Trial: 9447901
Drug: Ciprofloxacin for
RxNorm normalized name: Ciprofloxacin for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin for seven days, 500 mg b.i.d. (Group 1, 25 patients)
Trial: 9447901
Drug: Ciprofloxacin for
RxNorm normalized name: Ciprofloxacin for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin for ten days, 750 mg b.i.d. (Group 2, 25 patients)
Trial: 2881038
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (20 mg/kg intramuscularly daily for the first 3 days of life)
Trial: 25196897
Drug: Recombinant FVIII
RxNorm normalized name: HUMAN COAGULATION FACTOR VIII (FVIII, ANTIHEMOPHILIC FACTOR, AHF, PROCOAGULANT COMPONENT) WITH DELETED B-DOMAIN (746-1639)-SEQUENCE: SINGLE-CHAIN RECOMBINANT FVIII COMPOSED OF DOMAINS A1-A1-A2-A2 (1-740), THE B-DOMAIN N-AND C-TERMINAL FRAGMENTS (741-745)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant FVIII Fc fusion protein (rFVIIIFc) weekly prophylaxis
Trial: 31113841
Drug: Onalespib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onalespib (120 mg/m2 on day 1 and day 2 weekly for 3 of 4 weeks) + Abiraterone Acetate + Prednisone/Prednisolone
Trial: 23588127
Drug: Empiric antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric antibiotic treatment
Trial: 27759808
Drug: Maintenance modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance modified electroconvulsive therapy (MECT) combined with risperidone
Trial: 25662558
Drug: Methocarbamol/paracetamol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methocarbamol/paracetamol combination treatment
Trial: 22087616
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (20-minute massage by parents at home before bedtime every night for 5 weeks, in addition to standard asthma treatment)
Trial: 22087616
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard asthma treatment alone for 5 weeks)
Trial: 14673051
Drug: Itraconazole cyclodextrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole cyclodextrine solution
Trial: 10629018
Drug: Itraconazole capsules
RxNorm normalized name: Itraconazole Capsules
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole capsules
Trial: 10817039
Drug: Iopromide (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopromide (n = 16; median volume 102 ml; 95% confidence interval 90‐108 ml)
Trial: 10817039
Drug: Ioxaglate (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ioxaglate (n = 15; median volume 105 ml; 95% confidence interval 95‐114 ml)
Trial: 1918842
Drug: Sucralfate, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate, 2 g b.i.d.
Trial: 2093019
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg b.i.d.
Trial: 3932570
Drug: Proluton, 50‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proluton, 50‐mg daily injections given on days 7‐16 following oocyte recovery
Trial: 31838377
Drug: Sodium selenite
RxNorm normalized name: Sodium selenite
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sodium selenite (SS) 400 μg elemental Se, taken orally daily for 8 weeks
Trial: 31113455
Drug: LBEC0101 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBEC0101 (50 mg) administered subcutaneously once per week for 48 weeks
Trial: 12100776
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg twice daily
Trial: 11087881
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg daily
Trial: 1873773
Drug: Bolus doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doxorubicin (60 mg/m2 every 3 to 4 weeks)
Trial: 1873773
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion doxorubicin (60 mg/m2 every 3 to 4 weeks)
Trial: 1873773
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion doxorubicin
Trial: 7631286
Drug: Beta-blocking agents
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocking agents
Trial: 28752937
Drug: Internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered cognitive behaviour therapy (ICBT)
Trial: 12925474
Drug: Diclofenac 1.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1.1 mg kg(‐1) alone
Trial: 1737157
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg intravenously immediately, then three doses of 40 mg intravenously at eight hourly intervals, then 40 mg orally at 12 hourly intervals for four days
Trial: 20472045
Drug: Low-frequency ultrasound
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency ultrasound (US) applied during 5 min with a 36 kHz probe, pulsed mode (2s on/5s off), intensity of 2.72 W/cm², with betamethasone 17-valerate cream, 2-hour occlusion.
Trial: 20472045
Drug: Topical steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroids with 1-hour occlusion.
Trial: 18630537
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with massage of sole and oral administration of Alprazolam
Trial: 3595698
Drug: Nitrazepam 5
RxNorm normalized name: nitrazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam 5 mg
Trial: 7049583
Drug: Chlormezanone 400
RxNorm normalized name: chlormezanone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlormezanone 400 mg
Trial: 8315953
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy (control)
Trial: 25694153
Drug: Posterior scleral
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior scleral reinforcement (PSR) combined with patching therapy
Trial: 19145002
Drug: Low-sodium PD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium PD fluid with [Na+] = 102 mmol/l (group B)
Trial: 16887727
Drug: Artemether-lumefantrine treatment
RxNorm normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether-lumefantrine treatment
Trial: 15253711
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion in ESRD patients
Trial: 15253711
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion in healthy controls
Trial: 9052418
Drug: Clodronate (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (1600 mg daily) with antioestrogens
Trial: 9052418
Drug: Antioestrogens only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioestrogens only (20 mg tamoxifen or 60 mg toremifene daily)
Trial: 7689752
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 (PGE1) infusion during OLT
Trial: 27020594
Drug: Propofol (3-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (3-5 mg/kg i.v.)
Trial: 27020594
Drug: Sevoflurane (8%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane (8% inhaled)
Trial: 21346020
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for insomnia
Trial: 15651516
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml fentanyl
Trial: 8956390
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ketamine
Trial: 11705075
Drug: Pentaglobin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaglobin (5 ml/kg/day for 3 days)
Trial: 2655491
Drug: Placebo injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injections (alginate diluent with some containing 5 micrograms of histamine)
Trial: 31489422
Drug: HCQ+modified Xiaoyao
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCQ+modified Xiaoyao pill
Trial: 20605091
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (ascorbic acid 120 mg, vitamin E 30 mg, β-carotene 6 mg, selenium 100 μg, zinc 20 mg)
Trial: 9403646
Drug: Ibuprofen (10.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10.3 ± 1.9 mg/kg)
Trial: 9403646
Drug: Paracetamol (9.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (9.8 ± 1.9 mg/kg)
Trial: 20675882
Drug: Other drugs
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drugs and newly developed drugs
Trial: 23066663
Drug: Oral PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PUVA
Trial: 18219455
Drug: Shenyi Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenyi Capsule
Trial: 18219455
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (Shenyi Capsule plus chemotherapy)
Trial: 29945738
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg/day)
Trial: 17339122
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) administration
Trial: 6640551
Drug: 5‐FU at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐FU at a dose of 400 mg/m2/day iv X 5 plus TZT at a dose of 175 mg/m2/day iv X 3 (FT)
Trial: 6640551
Drug: 5‐FU at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐FU at a dose of 400 mg/m2/day plus ICRF‐159 at a dose of 600 mg/m2/day orally X 3 (FI)
Trial: 31034525
Drug: Balanced gelatine/electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced gelatine/electrolyte solution
Trial: 31034525
Drug: Non-balanced gelatine/electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-balanced gelatine/electrolyte solution
Trial: 9616507
Drug: Turbuhaler (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler (50 micrograms dose -1)
Trial: 9616507
Drug: pMDI (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pMDI (100 micrograms dose -1) with spacer (Volumatic)
Trial: 23650968
Drug: Oral transmucosal
RxNorm normalized name: Thrive, 2 mg oral transmucosal gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral transmucosal fentanyl citrate (OTFC)
Trial: 3182592
Drug: Ephedrine (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine (24 mg)
Trial: 31190492
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of auricular point pressing and EA
Trial: 18273622
Drug: Intravitreal injections
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injections of ranibizumab (3 injections)
Trial: 16828478
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OCs) for 21 days
Trial: 16828478
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRH-a) for 14 days
Trial: 9082867
Drug: Single-dose spinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose spinal anaesthesia (n = 150)
Trial: 3090127
Drug: Balloon reservoir
RxNorm normalized name: RESERVOIR,CADD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon reservoir volume of 3 l
Trial: 3090127
Drug: Balloon reservoir
RxNorm normalized name: RESERVOIR,CADD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon reservoir volume of 18 l
Trial: 3090127
Drug: Balloon reservoir
RxNorm normalized name: RESERVOIR,CADD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon reservoir volume of 24 l
Trial: 26684635
Drug: Methylsulfonylmethane (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylsulfonylmethane (5 g) and Boswellic acids (7.2 mg)
Trial: 18515507
Drug: Antibiotics (cefotetan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (cefotetan or cefoxitin)
Trial: 15937676
Drug: Video group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video group (one-time oral instruction by a physiotherapist and issued a video for home exercise)
Trial: 15937676
Drug: Training group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training group (exercise therapy; physiotherapist-guided; two times a week for 8 weeks)
Trial: 17876370
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin
Trial: 10816228
Drug: Control ointment
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control ointment (polysporin)
Trial: 8871001
Drug: Synchronous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synchronous chemotherapy with the 3M regimen (mitoxantrone, methotrexate and Mitomycin‐C) during radiotherapy (CRT)
Trial: 8871001
Drug: Synchronous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synchronous chemotherapy with the 3M regimen (CRT)
Trial: 1728624
Drug: Predetermined meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Predetermined meal three times daily (including cottage cheese, apple sauce, vanilla ice cream, and other selected foods)
Trial: 27552545
Drug: GH (0.67
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH (0.67 mg/m2 · d)
Trial: 16222518
Drug: Insulin-induced antilipolysis
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-induced antilipolysis and lipogenesis
Trial: 10468684
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg, amoxycillin 1 g, clarithromycin 500 mg (RAC)
Trial: 10468684
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg, metronidazole 400 mg, tetracycline 1 g (RMT)
Trial: 10468684
Drug: RBC 400
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC 400 mg plus clarithromycin 500 mg for 2 weeks (RC-2)
Trial: 8522636
Drug: Moexipril (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moexipril (7.5 mg and 15 mg once daily)
Trial: 8522636
Drug: Verapamil (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (180 mg and 240 mg once daily)
Trial: 1964898
Drug: Canned baked
RxNorm normalized name: BAKING POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canned baked beans (6 cans of 440 g per week)
Trial: 7457945
Drug: Fentanyl citrate
RxNorm normalized name: Fentanyl Citrate
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl citrate administered intramuscularly at 0.006 mg/kg
Trial: 7457945
Drug: Morphine chlorhydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine chlorhydrate administered at 0.150 mg/kg
Trial: 27655223
Drug: WBRT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WBRT plus 50 mg veliparib BID (n=103)
Trial: 27655223
Drug: WBRT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WBRT plus 200 mg veliparib BID (n=102)
Trial: 25872665
Drug: Jingui external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jingui external lotion
Trial: 16453952
Drug: Secondary intention
RxNorm normalized name: Secondary potassium phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secondary intention closure (gel foam applied for hemostasis)
Trial: 15602019
Drug: Palifermin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palifermin (60 microg/kg/day for 3 days before and after conditioning therapy)
Trial: 15602019
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous for 3 days before and after conditioning therapy)
Trial: 7923644
Drug: Heparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5000 U bolus and infusion of 1000 U/h for patients < 80 kg or 1300 U/h for patients >= 80 kg)
Trial: 15631970
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy website (MoodGYM) - public registrants
Trial: 8784087
Drug: Troglitazone 200
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 200 mg
Trial: 9667800
Drug: Troglitazone 200-600
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 200-600 mg
Trial: 11297595
Drug: Troglitazone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone (all doses)
Trial: 31886854
Drug: Preoperative screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative screening for Staphylococcus aureus nasal carriers and selective 5-day decolonization using mupirocin ointment (experimental group).
Trial: 24577485
Drug: High-dose edoxaban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose edoxaban
Trial: 24577485
Drug: Low-dose edoxaban
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose edoxaban
Trial: 18188164
Drug: Dual blockade
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual blockade treatment with candesartan (16 mg o.d.) and lisinopril (20 mg o.d.)
Trial: 18188164
Drug: High-dose lisinopril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose lisinopril (40 mg o.d.)